Valuation: Rapid Micro Biosystems, Inc.

Market Cap 99.33M 87.32M 81.29M 74.65M 140M 9.53B 142M 966M 377M 4.7B 373M 365M 16.26B P/E 2026 *
-2.16x
P/E 2027 * -2.54x
Enterprise Value 99.33M 87.32M 81.29M 74.65M 140M 9.53B 142M 966M 377M 4.7B 373M 365M 16.26B EV / Sales 2026 *
2.53x
EV / Sales 2027 * 2.13x
Free-Float
86.11%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-3.81%
Current month+16.76%
1 month+16.76%
3 months-17.89%
6 months-56.56%
Current year-30.34%
1 week 1.94
Extreme 1.94
2.15
1 month 1.68
Extreme 1.68
2.26
Current year 1.66
Extreme 1.66
4.94
1 year 1.66
Extreme 1.66
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
27.04
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap.
7/24/26 Fiscal year

Director

7,016 0.0155%
7/22/26 Fiscal year

Chief Executive Officer

2,804 0.0062%
5/29/26 Free

Chief Financial Officer

38,361 0.0921%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-3.81%-51.33%+98.04% 99.33M
+4.34%+9.96%+18.69%+2.45% 208B
+5.68%+13.01%-0.32%-22.21% 138B
+2.88%+5.34%-25.35%+12.93% 126B
+2.48%+7.52%-56.12%-10.16% 67.64B
+2.63%-0.21%+7.49%+0.75% 47.81B
+0.69%+2.98%-25.76%-32.46% 45.03B
+2.13%+4.30%+15.92%+9.94% 38.94B
+3.30%+2.85%+25.03%+32.28% 36.45B
+2.40%+5.23%-24.66%-7.67% 29.29B
Average +2.69%+0.64%-11.64%+8.39% 73.74B
Weighted average by Cap. +3.61%+1.40%-4.27%-2.30%

Financials

2026 *2027 *
Net sales 39.3M 34.55M 32.16M 29.54M 55.46M 3.77B 56.19M 382M 149M 1.86B 148M 144M 6.43B 46.58M 40.94M 38.11M 35M 65.73M 4.47B 66.59M 453M 177M 2.21B 175M 171M 7.62B
Net income -44.7M -39.3M -36.58M -33.59M -63.08M -4.29B -63.91M -435M -170M -2.12B -168M -164M -7.32B -39.07M -34.34M -31.97M -29.36M -55.13M -3.75B -55.86M -380M -148M -1.85B -147M -143M -6.39B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
26-07-28 US$2.020 +0.50% 577
26-07-27 US$2.010 +1.01% 77,533
26-07-24 US$1.990 0.00% 193,818
26-07-23 US$1.990 -3.40% 418,534
26-07-22 US$2.060 -1.90% 115,860
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.010USD
Average target price
6.667USD
Spread / Average Target
+231.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock